OpenAI has officially entered the field of AI-assisted drug discovery, challenging competitors such as Google and triggering sharp declines in the stock prices of related publicly traded companies.

Enterprise AI is moving beyond pilots. The real challenge now is turning experimentation into dependable business capability ...

OpenAI is rolling out an early version of an artificial intelligence model designed to accelerate drug discovery, joining a ...

OpenAI is releasing more than 90 new plugins. These connectors—including CircleCI, GitLab, and Microsoft Suite—allow the ...

As generative AI moves from research and development into enterprise-scale deployment, the underlying AI infrastructure is undergoing a structural realignment driven by a new phase of compute demand.

OpenAI updates Codex with automation, memory, computer control and 90 additional plugins, expanding it beyond coding to ...

Q2 Holdings has introduced Q2 Code, a new AI-powered development environment built in collaboration with Anthropic and Amazon Web Services, signaling a deeper shift in how software is created inside ...

Agentic swarms are coordinated networks of AI agents collaborating in parallel to code, test and optimize at unprecedented ...

While the model brings advanced capabilities, 5 new features could enhance your day-to-day interaction with the model across ...